Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.
Doriana LandiSilvia BartolomeoFrancesca BovisMaria Pia AmatoSimona BonavitaGiovanna BorrielloMaria BuccafuscaSebastiano BucelloPaola CavallaMaria CellerinoDiego CentonzeEleonora CoccoAntonella ConteAntonio CorteseEmanuele D'AmicoMassimiliano Di FilippoRenato DocimoRoberta FantozziElisabetta FerraroMassimo FilippiMatteo FoschiAntonio GalloFranco GranellaAntonio IannielloRoberta LanzilloLorena LoreficeMatteo LucchiniGiacomo LusGiorgia MataluniMassimiliano MirabellaMoiola LFrancesca NapoliCarolina Gabri NicolettiFrancesco PattiPaolo RagoneseSabrina RealmutoGiuseppe SchiròElisabetta SignorielloLeonardo SinisiMaria Laura StromilloValentina TomassiniDomizia VecchioMaria Pia SormaniGirolama Alessandra MarfiaPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
DMF discontinuation does not increase relapse risk during pregnancy. Early therapy restart prevents postpartum relapses. Early DMF exposure shows no adverse fetal outcomes.